Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Med (New York, N.Y.)
|
February 15, 2024
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie, Helen E Davies, Samuel B K Keat, et al.
Cancers
|
July 2, 2021
Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma
Julie A Webster, Alain Wuethrich, Karthik B Shanmugasundaram, et al.
Brain, Behavior, and Immunity
|
March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
The Journal of Infectious Diseases
|
December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement
Lisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Blood
|
May 19, 2025
Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI
Dawei Chen, Huaqin Liang, Xiuzhang Xu, et al.
Science Advances
|
July 9, 2025
Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors
Yue Li, Sarah Jacques, Hanmant Gaikwad, et al.
Annals of Clinical Biochemistry
|
December 3, 2020
Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens
Stuart J Moat, Wioleta M Zelek, Emily Carne, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 8, 2023
Factor XII promotes the thromboinflammatory response in a rat model of venoarterial extracorporeal membrane oxygenation
Mousa Kharnaf, Farhan Zafar, Spencer Hogue, et al.
Immunology
|
January 25, 2026
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID
Samuel B K Keat, Priyanka Khatri, Youssif M Ali, et al.
Journal of Innate Immunity
|
May 13, 2022
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex
Heidi Gytz Olesen, Iliana Michailidou, Wioleta M Zelek, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Med (New York, N.Y.)
|
February 15, 2024
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie, Helen E Davies, Samuel B K Keat, et al.
Cancers
|
July 2, 2021
Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma
Julie A Webster, Alain Wuethrich, Karthik B Shanmugasundaram, et al.
Brain, Behavior, and Immunity
|
March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
The Journal of Infectious Diseases
|
December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement
Lisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Blood
|
May 19, 2025
Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI
Dawei Chen, Huaqin Liang, Xiuzhang Xu, et al.
Science Advances
|
July 9, 2025
Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors
Yue Li, Sarah Jacques, Hanmant Gaikwad, et al.
Annals of Clinical Biochemistry
|
December 3, 2020
Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens
Stuart J Moat, Wioleta M Zelek, Emily Carne, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 8, 2023
Factor XII promotes the thromboinflammatory response in a rat model of venoarterial extracorporeal membrane oxygenation
Mousa Kharnaf, Farhan Zafar, Spencer Hogue, et al.
Immunology
|
January 25, 2026
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID
Samuel B K Keat, Priyanka Khatri, Youssif M Ali, et al.
Journal of Innate Immunity
|
May 13, 2022
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex
Heidi Gytz Olesen, Iliana Michailidou, Wioleta M Zelek, et al.
Page
of 5